Also known as: Avelox; Vigamox; Moxeza
Moxifloxacin is a high-purity Active Pharmaceutical Ingredient (API) classified as a Fluoroquinolone Antibiotic (4th Generation). Manufactured by Mediocon Inc in Aurangabad, Maharashtra, India at a GMP-certified facility, it is supplied in bulk for pharmaceutical formulations worldwide. CAS No: 151096-09-2.
| Parameter | Specification |
|---|---|
| CAS Number | 151096-09-2 |
| Molecular Formula | C₂₁H₂₄FN₃O₄ |
| Molecular Weight | 401.43 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Fluoroquinolone Antibiotic (4th Generation) |
| Appearance | Light yellow to yellow crystalline powder |
| Solubility | Slightly soluble in water; soluble in 0.1N hydrochloric acid |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | MOXI/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Moxifloxacin — CAS 151096-09-2 (CAS 151096-09-2) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Moxifloxacin — CAS 151096-09-2 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance